The International Myopia Institute (IMI) consensus group, comprised of key clinical researchers, scientists and eye care practitioners, has refocused efforts to ensure planned consensus reports are delivered in early 2021. The IMI recognises that many members have been affected by the COVID-19 pandemic and aim to continue their efforts to advance myopia research, education and advocacy during this time.
Taskforces have been implemented to bring consensus to the following areas:
Impact of myopia, chaired by Prof Padmaja Sankaridurg (Australia), paediatric high myopia chaired by Prof Ian Flitcroft (Ireland), high myopia in adults and their associated complications, chaired by Prof Kyoto Ohno-Matsui (Japan), preferred practice patterns (PPPS), chaired by Prof Jost Jonas (Germany), environmental risk factors in myopia, chaired by Prof Ian Morgan (Australian), accommodation and binocular vision in myopia, chaired by Nicola Logan (UK), and yearly digest 2020, chaired by Prof Earl Smith (US) and Dr Monica Jong (Australian).
The International Myopia Institute (IMI) consensus group… has refocused efforts to ensure planned consensus reports are delivered in early 2021
The IMI has also produced new white papers which continue from the initial papers published in 2019 in the journal Investigative Ophthalmology and Visual Science (IOVS). The current white papers and clinical summaries are available here.
“”
